Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reviva Pharmaceuticals Holdings, Inc. - Common Stock (NQ:RVPH)

0.7886 -0.0637 (-7.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 394,040
Open 0.8300
Bid (Size) 0.7900 (4)
Ask (Size) 0.8565 (2)
Prev. Close 0.8523
Today's Range 0.7818 - 0.8771
52wk Range 0.4850 - 4.280
Shares Outstanding 22,650,266
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Tuesday's session
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill

Performance

YTD
-60.8%
-60.8%
1 Month
+31.4%
+31.4%
3 Month
-61.0%
-61.0%
6 Month
-13.9%
-13.9%
1 Year
-73.2%
-73.2%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Ulta Beauty To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Applied Therapeutics Appoints John H. Johnson as Executive Chairman
From Applied Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Via Benzinga
Exposures Product Safety
RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024
Via InvestorPlace
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q1 2024
Via InvestorPlace
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH
From The Rosen Law Firm, P.A.
Via Business Wire
REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
Via InvestorPlace
Reviva to Present at Webull LIVE! Healthcare Webinar on January 17
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Reviva Pharmaceuticals Holdings, Inc. - Common Stock publicly traded?
Yes, Reviva Pharmaceuticals Holdings, Inc. - Common Stock is publicly traded.
What exchange does Reviva Pharmaceuticals Holdings, Inc. - Common Stock trade on?
Reviva Pharmaceuticals Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Reviva Pharmaceuticals Holdings, Inc. - Common Stock?
The ticker symbol for Reviva Pharmaceuticals Holdings, Inc. - Common Stock is RVPH on the Nasdaq Stock Market
What is the current price of Reviva Pharmaceuticals Holdings, Inc. - Common Stock?
The current price of Reviva Pharmaceuticals Holdings, Inc. - Common Stock is 0.7886
When was Reviva Pharmaceuticals Holdings, Inc. - Common Stock last traded?
The last trade of Reviva Pharmaceuticals Holdings, Inc. - Common Stock was at 05/06/25 04:00 PM ET
What is the market capitalization of Reviva Pharmaceuticals Holdings, Inc. - Common Stock?
The market capitalization of Reviva Pharmaceuticals Holdings, Inc. - Common Stock is 17.86M
How many shares of Reviva Pharmaceuticals Holdings, Inc. - Common Stock are outstanding?
Reviva Pharmaceuticals Holdings, Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.